Meningioma trials in China

In China 8 Also abroad 73

8 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 2Not yet taking people in China
Selumetinib for NF2-Related Schwannomatosis
Where
Beijing
Age
3 years and over
People
20
Run by
Beijing Tiantan Hospital
See details and how to joinNCT07707947
Phase 1Taking people
IN10018 in Combination With Dalpiciclib for Progressive Meningiomas
Where
Beijing
Age
18 years and over
People
24
Run by
Capital Medical University
See details and how to joinNCT07652762
Phase 2Not yet taking people in China
Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2)
Where
Beijing, Changchun, Shanghai
People
200
Run by
Beijing Tiantan Hospital
See details and how to joinNCT07713745
Phase 1/2Not yet taking people in China
Luvometinib in Combination With Serplulimab for NF2-Related Tumors
Where
Beijing, Changchun, Shanghai
Age
18 years and over
People
30
Run by
Beijing Tiantan Hospital
See details and how to joinNCT07708285
No phaseTaking people
NK Cell Therapy for Malignant Solid Brain Tumors
Where
Beijing, Qinhuangdao, Zhengzhou
Age
18 years to 70 years
People
27
Run by
Peking University Third Hospital
See details and how to joinNCT07552233
No phaseTaking people
MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment
Where
Shenyang
Age
18 years to 80 years
People
20
Run by
Shengjing Hospital
See details and how to joinNCT05957679
No phaseTaking people
3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological Features
Where
Shenyang
Age
18 years to 80 years
People
300
Run by
Shengjing Hospital
See details and how to joinNCT06955208
Phase 1/2Taking people
TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
Where
Beijing
Age
16 years to 90 years
People
85
Run by
Essen Biotech
See details and how to joinNCT06640582